Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

Simon T. Durrant; Arnon Nagler; Paola Guglielmelli; David Lavie; Philipp le Coutre; Heinz Gisslinger; Charles Chuah; Margherita Maffioli; Savita Bharathy; Tuochuan Dong; Monika Wroclawska; Joaquin Martinez Lopez

doi:10.3324/haematol.2018.209965

Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

Simon T. Durrant^*, Arnon Nagler, Paola Guglielmelli, David Lavie, Philipp le Coutre, Heinz Gisslinger, Charles Chuah, Margherita Maffioli, Savita Bharathy, Tuochuan Dong, Monika Wroclawska, Joaquin Martinez Lopez

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E551-E554
Journal	Haematologica
Volume	104
Issue number	12
DOIs	https://doi.org/10.3324/haematol.2018.209965
State	Published - 2019
Externally published	Yes

Access to Document

10.3324/haematol.2018.209965

Cite this

Durrant, S. T., Nagler, A., Guglielmelli, P., Lavie, D., le Coutre, P., Gisslinger, H., Chuah, C., Maffioli, M., Bharathy, S., Dong, T., Wroclawska, M., & Lopez, J. M. (2019). Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis. Haematologica, 104(12), E551-E554. https://doi.org/10.3324/haematol.2018.209965

@article{a95f84479e9e450a9d4d2b0ddb5e23f2,

title = "Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis",

author = "Durrant, {Simon T.} and Arnon Nagler and Paola Guglielmelli and David Lavie and {le Coutre}, Philipp and Heinz Gisslinger and Charles Chuah and Margherita Maffioli and Savita Bharathy and Tuochuan Dong and Monika Wroclawska and Lopez, {Joaquin Martinez}",

note = "Funding Information: the Novartis Pharmaceuticals Corporation",

year = "2019",

doi = "10.3324/haematol.2018.209965",

language = "אנגלית",

volume = "104",

pages = "E551--E554",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

Durrant, ST, Nagler, A, Guglielmelli, P, Lavie, D, le Coutre, P, Gisslinger, H, Chuah, C, Maffioli, M, Bharathy, S, Dong, T, Wroclawska, M & Lopez, JM 2019, 'Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis', Haematologica, vol. 104, no. 12, pp. E551-E554. https://doi.org/10.3324/haematol.2018.209965

Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis. / Durrant, Simon T.; Nagler, Arnon; Guglielmelli, Paola et al.
In: Haematologica, Vol. 104, No. 12, 2019, p. E551-E554.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Results from Harmony

T2 - An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

AU - Durrant, Simon T.

AU - Nagler, Arnon

AU - Guglielmelli, Paola

AU - Lavie, David

AU - le Coutre, Philipp

AU - Gisslinger, Heinz

AU - Chuah, Charles

AU - Maffioli, Margherita

AU - Bharathy, Savita

AU - Dong, Tuochuan

AU - Wroclawska, Monika

AU - Lopez, Joaquin Martinez

N1 - Funding Information: the Novartis Pharmaceuticals Corporation

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85074039445&partnerID=8YFLogxK

U2 - 10.3324/haematol.2018.209965

DO - 10.3324/haematol.2018.209965

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 31073072

AN - SCOPUS:85074039445

SN - 0390-6078

VL - 104

SP - E551-E554

JO - Haematologica

JF - Haematologica

IS - 12

ER -

Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

Access to Document

Other files and links

Cite this